117 related articles for article (PubMed ID: 38140739)
1. The predictive efficacy of programmed cell death in immunotherapy of melanoma: A comprehensive analysis of gene expression data for programmed cell death biomarker and therapeutic target discovery.
Yue C; Lian W; Duan M; Xia D; Cao X; Peng J
Environ Toxicol; 2024 Mar; 39(3):1858-1873. PubMed ID: 38140739
[TBL] [Abstract][Full Text] [Related]
2. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.
Xie Y; Xu Z; Mei X; Shi W
Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
[TBL] [Abstract][Full Text] [Related]
3. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
Wu M; Wang Z; Zhang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy.
Xu Z; Xie Y; Mao Y; Huang J; Mei X; Song J; Sun Y; Yao Z; Shi W
Front Genet; 2021; 12():758981. PubMed ID: 34804126
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel tumour microenvironment-based prognostic biomarker in skin cutaneous melanoma.
Yang RH; Liang B; Li JH; Pi XB; Yu K; Xiang SJ; Gu N; Chen XD; Zhou ST
J Cell Mol Med; 2021 Dec; 25(23):10990-11001. PubMed ID: 34755462
[TBL] [Abstract][Full Text] [Related]
6. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
8. Identification of Pyroptosis-Relevant Signature in Tumor Immune Microenvironment and Prognosis in Skin Cutaneous Melanoma Using Network Analysis.
Zhu Y; Han D; Duan H; Rao Q; Qian Y; Chen Q; Du X; Ni H; Wang S
Stem Cells Int; 2023; 2023():3827999. PubMed ID: 36818162
[TBL] [Abstract][Full Text] [Related]
9. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.
Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J
Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879
[TBL] [Abstract][Full Text] [Related]
10. Integrative lactylation and tumor microenvironment signature as prognostic and therapeutic biomarkers in skin cutaneous melanoma.
Zhu Y; Song B; Yang Z; Peng Y; Cui Z; Chen L; Song B
J Cancer Res Clin Oncol; 2023 Dec; 149(20):17897-17919. PubMed ID: 37955686
[TBL] [Abstract][Full Text] [Related]
11. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.
Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675
[TBL] [Abstract][Full Text] [Related]
12. Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
Feng S; Wang Z; Zhang H; Hou B; Xu Y; Hao S; Lu Y
J Gene Med; 2024 Jan; 26(1):e3643. PubMed ID: 38044747
[TBL] [Abstract][Full Text] [Related]
13. Analysis of differential gene immune infiltration and clinical characteristics of skin cutaneous melanoma based on systems biology and drug repositioning methods to identify drug candidates for skin cutaneous melanoma.
Long S; Xu J; Huang H
Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2427-2447. PubMed ID: 37086280
[TBL] [Abstract][Full Text] [Related]
14. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract][Full Text] [Related]
15. Identification of anoikis-related subtypes and development of risk stratification system in skin cutaneous melanoma.
Tian J; Cao ZJ; Zhang Y; Zhou JK; Yang L
Heliyon; 2023 May; 9(5):e16153. PubMed ID: 37215879
[TBL] [Abstract][Full Text] [Related]
16. A Novel Ferroptosis-Related lncRNA Prognostic Model and Immune Infiltration Features in Skin Cutaneous Melanoma.
Sun S; Zhang G; Zhang L
Front Cell Dev Biol; 2021; 9():790047. PubMed ID: 35186949
[No Abstract] [Full Text] [Related]
17. System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma.
Zhao S; Zhu Y; Liu H; He X; Xie J
J Transl Med; 2023 Nov; 21(1):801. PubMed ID: 37950289
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of Necroptosis Landscape in Skin Cutaneous Melanoma for Appealing its Implications in Prognosis Estimation and Microenvironment Status.
Cao X; He J; Chen A; Ran J; Li J; Chen D; Zhang H
J Pers Med; 2023 Jan; 13(2):. PubMed ID: 36836481
[TBL] [Abstract][Full Text] [Related]
19. A new ferroptosis-related genetic mutation risk model predicts the prognosis of skin cutaneous melanoma.
He J; Huang W; Li X; Wang J; Nie Y; Li G; Wang X; Cao H; Chen X; Wang X
Front Genet; 2022; 13():988909. PubMed ID: 36685905
[No Abstract] [Full Text] [Related]
20. Coexpressed Genes That Promote the Infiltration of M2 Macrophages in Melanoma Can Evaluate the Prognosis and Immunotherapy Outcome.
Yan K; Wang Y; Lu Y; Yan Z
J Immunol Res; 2021; 2021():6664791. PubMed ID: 33748290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
